E Rüther

Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).

E. Rüther, M. Windisch, M Windisch, 1994, Pharmacopsychiatry.

Assessing the efficacy of treatments for panic disorder and agoraphobia. I. Methodological problems

E. Rüther, G. Hajak, B. Bandelow, 1995, International clinical psychopharmacology.

Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.

E. Rüther, G. Emilien, R. Élie, 1999, The Journal of clinical psychiatry.

Chronic manganism: fourteen years of follow-up.

R Sprung, W Poser, E. Rüther, 1999, The Journal of neuropsychiatry and clinical neurosciences.